Axcelead is the first integrated drug discovery solutions provider in the pharmaceutical industry in Japan.
Scope of Business: Providing advisory and research services on drug discovery, etc.
Axcelead offer a comprehensive set of best-in-class capabilities to meet a range of customer needs.
Capability: Screening (Hit finding, Lead generation/optimization, Compound library management), Chemistry (Medicinal Chemistry, Peotide chemistry, Synthetic chemistry, High-throughput synthesis, Analytical chemistry, Computational chemistry), Biology (Pharmacology studies in oncology, immunological disorders, central nervous system diseases, cardiovascular diseases metabolic diseases, gastrointestinal motility disorders, and cell therapy using large animals, Omics, Bioinformatics, Genetically modified animals (mics), DMPK (ADME screening, Discovery DMPK studies, Physicochemistry and preformulation, studies, Pre-clinical development), Safety (In vitro and in vivo exploratory safety studies, IND/NDA enabling, Toxicity mechanism studies/Target validation/Efficacy studies, Consulting services)